| Financial Year |
March 31 2023 |
| Monetary Funds |
250,007,498.58 |
| Held-for-trading Financial Assets |
600,579,166.67 |
| Notes Receivable |
26,668,380.62 |
| Accounts Receivable |
468,604,223.39 |
| Advances to Suppliers |
115,184,574.06 |
| Other Receivables |
12,838,519.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
546,947,299.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,386,145.89 |
| Other Current Assets |
160,117,091.80 |
| Total Current Assets |
2,237,262,970.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
435,705.40 |
| Long-term Equity Investment |
3,416,948.38 |
| Investment Properties |
324,099.97 |
| Fixed Assetes |
312,378,295.56 |
| Under-construction Projects |
29,358,279.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
94,726,362.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,962,843.03 |
| Deferred Income Tax Assets |
33,510,323.89 |
| Other Non-Current Assets |
3,081,056.90 |
| Sub-Total of Non-Current Assets |
481,579,458.67 |
| Total Assets |
2,718,842,428.81 |
| Short-Term Loans |
24,000,000.00 |
| Trading Financial liabilities |
6,723.14 |
| Notes Payable |
97,865,722.50 |
| Accounts Payable |
271,526,980.40 |
| Accounts Received In Advance |
17,505,503.39 |
| Employee Compensation Payable |
29,791,624.71 |
| Taxes Payable |
2,837,703.48 |
| Interest Payable |
225,423.91 |
| Dividend Payable |
18,099,115.97 |
| Other payables |
196,829,933.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,290,289.54 |
| Other Current Liabilities |
5,770,461.78 |
| Sub-Total of Current Liabilities |
803,166,638.05 |
| Long-term Loans |
103,544,036.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
12,732,174.62 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,257,567.55 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
249,970,552.99 |
| Total Liabilities |
1,053,137,191.04 |
| Paid-In Capital(Or Share Stock) |
1,774,094,480.00 |
| Capital Surplus |
3,920,395,908.76 |
| Surplus Reserve |
274,265,798.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,480,560,938.88 |
| Minority Stockholder's Interest |
174,793,863.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,490,911,373.85 |
| Owner's Equity（Stockholder's Equity） |
1,665,705,237.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,718,842,428.81 |
